USPTO Publishes Four RNAi-Related Patent Applications

Jun 14, 2007

Premium

Title: Methods and Compositions for Gene Silencing

Numbers: 20070130653

Filed: June 6, 2006

Lead Inventor: David Baulcombe, Pioneer Hi-Bred, EI DuPont, Plant Biosciences

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

The Preliminary Investigation

Chinese state news agency Xinhua reports that a preliminary investigation has found He Jiankui performed his gene-editing work illegally.

John Mendelsohn Dies

John Mendelsohn, a former president of the University of Texas MD Anderson Cancer Center, has died, the New York Times reports.

Similar, But Not Quite the Same

Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.

This Week in PNAS

In PNAS this week: chromosomal features of maize, adaptations in the vinous-throated parrotbill, and more.

Featured White Papers

Controlling Ribonuclease (RNase) with High Irradiance UV LED Light Engines

The Ultimate Guide to Mouse Clinical Trials

High Throughput RT-qPCR for Gene Expression Analysis

Feb

21

Featured Webinar

Case Study: 'Companion Informatics' to Automate Immunotherapy Manufacturing and Treatment

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Main menu